Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging

被引：3

作者：

Anisimov, VN

Khavinsov, VK

Alimova, IN

Provintsiali, M

Manchini, R

Francheski, K

机构：

[1] Russian Acad Med Sci, St Petersburg Inst Bioregulat & Gerontol, NW Div, Moscow 109801, Russia

[2] Russian Minist Hlth, NN Petrov Inst Oncol, Dept Carcinogenesis & Oncogerontol, St Petersburg, Russia

[3] Italian Natl Res Ctr Aging, Ancona, Italy

来源：

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2002年 / 133卷 / 02期

关键词：

transgenic mice; HER-2/neu; breast cancer; peptides; Epithalon; Vilon;

D O I：

10.1023/A:1015555023692

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Female transgenic FVB mice carrying breast cancer gene HER-2/neu were monthly injected with Vilon or Epithalon (1 mug subcutaneously for 5 consecutive days) starting from the 2nd month of life. Epithalon markedly inhibited neoplasm development: the maximum size of breast adenacarcinomas was 33% lower than in the control (p<0.05). The intensity of HER-2/neu mRNA expression in breast tumors of Epithalon-treated mice was 3.7 times lower than in control animals. These results indicate that Epithalon inhibited breast tumor development in transgenic mice, which is probably related to suppression of HER-2/neu expression.

引用

页码：167 / 170

页数：4

共 50 条

[41] Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
Anisimov, VN
Khavinson, VKH
Provinciali, M
Alimova, IN
Baturin, DA
Popovich, IG
Zabezhinski, MA
Imyanitov, EN
Mancini, R
Franceschi, C
[J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) : 7 - 10
[42] Effect of annatto-tocotrienols supplementation on the Development of Mammary Tumors in HER-2/neu Transgenic Mice
Pierpaoli, E.
Viola, V.
Barucca, A.
Orlando, F.
Galli, F.
Provinciali, M.
[J]. FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S46 - S47
[43] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene expression in breast cancer
Gupta, D
Middleton, LP
Whitaker, MJ
Abrams, J
[J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 322A - 322A
[44] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene expression in breast cancer
Gupta, D
Middleton, LP
Whitaker, MJ
Abrams, J
[J]. MODERN PATHOLOGY, 2003, 16 (01) : 322A - 322A
[45] HER-2/neu expression regulates the immune response and tumor senescence in breast cancer
Rosemblit, Cinthia
Cintolo-Gonzalez, Jessica
Xu, Shuwen
Czerniecki, Brian J.
[J]. MOLECULAR CANCER RESEARCH, 2013, 11
[46] Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
Anisimov, VN
Berstein, LM
Egormin, PA
Piskunova, TS
Popovich, IG
Zabezhinski, MA
Kovalenko, IG
Poroshina, TE
Semenchenko, AV
Provinciali, M
Re, F
Franceschi, C
[J]. EXPERIMENTAL GERONTOLOGY, 2005, 40 (8-9) : 685 - 693
[47] EXPRESSION OF HER-2/NEU ONCOGENE IN BREAST-CANCER - CORRELATION OF QUANTITATIVE IMMUNOCYTOCHEMISTRY AND PROGNOSTIC FACTORS
CHARPIN, C
DEVICTOR, B
BONNIER, P
ANDRAC, L
LAVAUT, MN
ALLASIA, C
PIANA, L
[J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (07) : 815 - 823
[48] CORRELATION OF HER-2/NEU ONCOGENE EXPRESSION TO DNA PLOIDY DISTRIBUTION, AND PROLIFERATION INDEX IN BREAST CANCERS
BACUS, SS
RUBY, SG
WEINBERG, DS
PRESS, MF
SLAMON, DJ
[J]. LABORATORY INVESTIGATION, 1990, 62 (01) : A6 - A6
[49] THE HER-2/NEU ONCOGENE IN BREAST-CANCER - SO WHAT IS NEW
LEVINE, MN
ANDRULIS, I
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1034 - 1036
[50] HER-2/NEU ONCOGENE PROTEIN AS A PROGNOSTIC FACTOR IN BREAST-CANCER
TANDON, AK
CLARK, GM
ULLRICH, A
MCGUIRE, WL
[J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 107 - 107

← 1 2 3 4 5 →